| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.40▲ | 2.40▲ | 2.39▲ | 2.59▼ | 2.79▼ |
| MA10 | 2.40▲ | 2.39▲ | 2.35▲ | 2.67▼ | 2.61▼ |
| MA20 | 2.41▼ | 2.35▲ | 2.43▼ | 2.88▼ | 2.16▲ |
| MA50 | 2.38▲ | 2.51▼ | 2.60▼ | 2.63▼ | 2.65▼ |
| MA100 | 2.35▲ | 2.62▼ | 2.82▼ | 2.15▲ | 3.41▼ |
| MA200 | 2.46▼ | 2.84▼ | 2.80▼ | 2.29▲ | 3.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.021▲ | 0.014▲ | -0.088▼ | 0.108▲ |
| RSI | 54.545▲ | 49.809▼ | 42.980▼ | 39.528▼ | 49.352▼ |
| STOCH | 61.111 | 83.341▲ | 77.039 | 22.958 | 68.329 |
| WILL %R | -33.333 | -9.375▲ | -49.296 | -83.019▼ | -49.326 |
| CCI | 8.408 | 74.393 | 109.015▲ | -145.017▼ | 15.068 |
| MA | $BDTX Price Crossed Above MA(200) | Set Alert |
|
Saturday, August 09, 2025 06:23 AM
NasdaqGS:BDTX 1 Year Share Price vs Fair Value Explore Black Diamond Therapeutics's Fair Values from the Community ...
|
|
Thursday, August 07, 2025 06:22 AM
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025Exploring partnership oppo ...
|
|
Thursday, August 07, 2025 04:41 AM
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025Exploring partnership ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/08/25 | 2.28 | 2.425 | 2.2521 | 2.40 | 748,229 |
| 07/08/25 | 2.58 | 2.60 | 2.22 | 2.28 | 1,878,624 |
| 06/08/25 | 2.76 | 2.765 | 2.59 | 2.69 | 578,474 |
| 05/08/25 | 2.84 | 2.87 | 2.69 | 2.73 | 765,865 |
| 04/08/25 | 2.60 | 2.86 | 2.60 | 2.83 | 751,938 |
| 01/08/25 | 2.60 | 2.625 | 2.52 | 2.59 | 708,570 |
| 31/07/25 | 2.81 | 2.8536 | 2.645 | 2.66 | 805,684 |
| 30/07/25 | 2.84 | 2.97 | 2.795 | 2.82 | 670,100 |
| 29/07/25 | 2.93 | 2.935 | 2.73 | 2.78 | 1,300,534 |
| 28/07/25 | 3.01 | 3.08 | 2.91 | 2.93 | 542,139 |
|
|
||||
|
|
||||
|
|